Immune response to pandemic H1N1 2009 in
β
Wolfram Haller; Jim Buttery; Karen Laurie; Kathe Beyerle; Winita Hardikar; Georg
π
Article
π
2011
π
John Wiley and Sons
π
English
β 422 KB
After the announcement of a worldwide pandemic in June 2009, a single dose of a monovalent pandemic H1N1 2009 influenza A (pH1N1/09) vaccine was advocated for all Australians who were 10 years and older because of excellent immunogenicity trial results for healthy children and adults. Immunocompromi